Navigation Links
Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform
Date:6/25/2009

PRINCETON, N.J., June 25 /PRNewswire/ -- "Congratulations President Obama on your agreement with large pharmaceutical companies to cut prescription costs for the elderly," says Mark D. Steele, president of NeoStrata Company, Inc. "We thought you should know that you have a little company in New Jersey that's done the same for psoriasis sufferers of all ages."

Mr. Steele is speaking about NeoStrata Company, Inc., and the submission of their findings from a recent clinical study announcing the significant cost-savings associated with their non-prescription, psoriasis medicine PSORENT(R) psoriasis topical solution.

Earlier this week, NeoStrata Company, Inc. submitted results for publication from an 18 week long clinical study demonstrating how psoriasis patients can save hundreds of dollars a year with their novel, non-prescription psoriasis therapy that has outperformed the leading non-steroidal prescription topical in treating the redness and scaling of psoriasis.

"In these economic times we are thrilled to be able to offer a psoriasis medicine that does not require a prescription, is significantly less expensive than most prescription drugs for psoriasis, and performs as well or better than a leading prescription medication," says Mr. Steele.

"This is not a story you hear very often, and as a small company," he explains, "we are just very excited and proud of this new psoriasis therapy and of the value it presents to patients."

NeoStrata Company, Inc. has spent the last few years developing PSORENT(R) and conducting clinical studies and after just receiving the cost savings analyses agrees the timing couldn't be better in tune with what's happening in the economy.

"As a small company," Steele explains, "we have created an affordable and preferable treatment for psoriasis that can save patients hundreds and thousands of dollars in healthcare costs, and we
'/>"/>

SOURCE NeoStrata Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Innovative Brain Scanning for Alzheimers Screening Unveiled
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ... practice of dermatology for clinical and aesthetic dermatology practitioners ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ... VSRNAs are of molecular size less than 10 bps, ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ... Summary,Although the past decade has ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
(Date:3/10/2014)... team of scientists at Washington University School of Medicine ... (UA) in Tucson led by Samuel Achilefu have created ... cancer cells during surgeries, which glow blue when viewed ... he coauthored as part of a special section in ... fluorescence molecular imaging that details the development of the ...
(Date:3/9/2014)... (March 10, 2014) Irritable bowel syndrome (IBS) belongs ... causing up to sixty per cent of the ... frequent symptoms of IBS is bloating, which reduces ... as particularly bothersome. For quite a long time, ... condition. , "Contrary to this view, recent findings ...
(Date:3/7/2014)... has been the focus of a growing body of ... Academy of Child and Adolescent Psychiatry to revise key ... Yale Child Study Center director Fred Volkmar, M.D., have ... of the Journal of the American Academy of ... of children with autism spectrum disorders means treatments will ...
(Date:3/7/2014)... PHOENIX, Ariz. March 7, 2014 In ... of Clinical Oncology (ASCO) has named Dr. Daniel ... Luminaries, celebrating 50 doctors who over the past ... Dr. Von Hoff, M.D., FACP, is Physician-In-Chief and ... (TGen), and Chief Scientific Officer for Scottsdale Healthcare,s ...
(Date:3/7/2014)... only had one glass of wine with dinner, but if ... hard enough to make you a dangerous driver., So, baby ... you used to. , Sara Jo Nixon, Ph.D., a professor ... of Florida and doctoral candidate Alfredo Sklar tested how drinking ... two age groups: 36 people ages 25 to 35 and ...
Breaking Medicine News(10 mins):Health News:New high-tech glasses detect cancer cells during surgery 2Health News:IBS and bloating: When the gut microbiota gets out of balance 2Health News:IBS and bloating: When the gut microbiota gets out of balance 3Health News:New guidelines employ a team approach to autism diagnosis and care 2Health News:TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO 2Health News:For older drivers, study finds, 1 drink may be 1 too many 2Health News:For older drivers, study finds, 1 drink may be 1 too many 3
... By Denise Mann HealthDay Reporter , MONDAY, ... up to 80 percent more likely to develop inflammatory bowel ... women without the uterine disorder, according to a new long-term ... lining -- the endometrium -- grows outside of the ...
... of cancer recurrence and cancer-related death in patients with esophageal ... Clinic found. Their 778-patient study, which appeared in the Dec. ... ( http://jco.ascopubs.org/ ), found that five-year survival in obese patients ... higher -- with esophageal cancer was 18 percent, compared to ...
... have been shown to have higher levels of education ... physically active, and have other characteristics that are associated ... been inconsistent in showing that, after adjustment for all ... of cardiovascular disease and mortality than do consumers of ...
... patterns of emergency care for an entire state has ... Indiana over a three-year period were by patients who ... conventional wisdom that patients are tightly bound to health ... The Regenstrief Institute study, "All Health Care Is ...
... "hypersensitive" they,re thought to be more fearful and feel ... Tel Aviv University shows that the anxious may not be ... sensitive enough. As part of a study on how ... Frenkel, a Ph.D. candidate in TAU,s School of Psychological Sciences ...
... Reporter , MONDAY, Dec. 19 (HealthDay News) -- Young women ... less time sunbathing or using tanning beds, two riskier behaviors, ... tanning product is a safe alternative to ultraviolet radiation (UV) ... the researchers said. They found that women who used tanning ...
Cached Medicine News:Health News:Endometriosis Tied to Higher Risk of Crohn's, Colitis 2Health News:Obesity linked to higher 5-year death rate after esophageal cancer surgery 2Health News:First study of emergency care for an entire state finds care isn't always local 2Health News:Are the anxious oblivious? 2Health News:Bottled Tan May Keep Women Out of the Sun 2Health News:Bottled Tan May Keep Women Out of the Sun 3
ELISA kit for Varicella-zoster IgG detection....
Varicella-zoster virus (VZV) IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection of IgM antibody to Varicella-zoster virus in human serum as an aid in the diagnosis of primar...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
Inquire...
Medicine Products: